Capivasertib-Fulvestrant Therapy Increases PFS in HR-Positive Breast Cancer
Elana Gotkine
MONDAY, June 5, 2023 (HealthDay News) -- For patients with hormone receptor-positive advanced breast cancer with disease progression during or after treatment with an aromatase…